Cargando…

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide

The use of cancer chemotherapy and hyperthermia as part of a surgical procedure in the management of patients with peritoneal carcinomatosis has gained prominence in recent years with selected patients showing benefit. Patients with peritoneal surface malignancy following cancer resection were treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van der Speeten, Kurt, Stuart, O. Anthony, Mahteme, Haile, Sugarbaker, Paul H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263669/ https://www.ncbi.nlm.nih.gov/pubmed/22312496 http://dx.doi.org/10.1155/2011/185092

Ejemplares similares

Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients
por: Van der Speeten, K., et al.
Publicado: (2012)

Using Pharmacologic Data to Plan Clinical Treatments for Patients with Peritoneal Surface Malignancy
por: Van der Speeten, Kurt, et al.
Publicado: (2009)

Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
por: Lemoine, Lieselotte, et al.
Publicado: (2016)

Body surface area-based versus concentration-based intraperitoneal perioperative chemotherapy in a rat model of colorectal peritoneal surface malignancy: pharmacologic guidance towards standardization
por: Lemoine, Lieselotte, et al.
Publicado: (2019)

Phase I and pharmacokinetic study of the combination of topotecan and ifosfamide administered intravenously every 3 weeks
por: Kerbusch, T, et al.
Publicado: (2004)

Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients
por: Sugarbaker, Paul H., et al.
Publicado: (2020)

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide
por: Rezaï, Keyvan, et al.
Publicado: (2007)

BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis
por: Willaert, Wouter, et al.
Publicado: (2015)

Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival
por: Bijelic, Lana, et al.
Publicado: (2012)

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012)

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies
por: Hamberg, P, et al.
Publicado: (2010)

Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin
por: Madrigal-Bujaidar, Eduardo, et al.
Publicado: (2019)

The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
por: Singer, J. M., et al.
Publicado: (1998)

Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin
por: Sohail, Mohammad A., et al.
Publicado: (2021)

Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006)

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
por: Casado-Adam, Angela, et al.
Publicado: (2011)

Modulation of P450-dependent ifosfamide pharmacokinetics: a better understanding of drug activation in vivo.
por: Brain, E. G., et al.
Publicado: (1998)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
por: Willits, I, et al.
Publicado: (2005)

Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients
por: Preti, Vinicius, et al.
Publicado: (2012)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Cytoreductive Surgery Plus Hyperthermic Perioperative Chemotherapy for Selected Patients with Peritoneal Metastases from Colorectal Cancer: A New Standard of Care or an Experimental Approach?
por: Sugarbaker, Paul H.
Publicado: (2012)

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.
por: Pronk, L. C., et al.
Publicado: (1998)

Randomized trial of intravenous versus bidirectional chemotherapy after cytoreductive surgery for malignant peritoneal mesothelioma
por: Sugarbaker, Paul H.
Publicado: (2023)

Systemic complications of the bidirectional intraoperative chemotherapy with intravenous ifosfamide and hyperthermic intraperitoneal chemotherapy (HIPEC) using cisplatin plus doxorubicin
por: Hakeam, Hakeam, et al.
Publicado: (2019)

The influence of ifosfamide scheduling on acute nephrotoxicity in children.
por: English, M. W., et al.
Publicado: (1997)

Intraperitoneal doxorubicin achieves access to mesenteric lymph nodes, case series of two patients()
por: Sugarbaker, Paul H., et al.
Publicado: (2018)

The Utility of Intravenous Acetaminophen in the Perioperative Period
por: O’Neal, Jason B.
Publicado: (2013)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

Karyomegalic interstitial nephropathy following ifosfamide therapy
por: Jayasurya, R., et al.
Publicado: (2016)

Covariates of intravenous paracetamol pharmacokinetics in adults
por: Allegaert, Karel, et al.
Publicado: (2014)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
por: Bijelic, Lana, et al.
Publicado: (2012)

An Unusual Case of Peritoneal Carcinomatosis
por: Hillewaere, Stijn, et al.
Publicado: (2010)

Rhabdomyolysis after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report
por: Bielen, Rob, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fkpndrue11k7qclmpe5tfik6ba